secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seer, Inc. (SEER)
CIK:        0001726445
Form:       8-K
Filed at:   2026-05-13T20:19:36+00:00
Accession:  0001193125-26-221696
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seer Q1 2026 revenue $2.8M (-34% YoY); reaffirms FY2026 guidance of $16M-$18M
-----------------------------------------------------------------------------

- Revenue $2.8M, down 34% from $4.2M YoY, driven by depressed academic funding and competitive activity.
- Net loss $16.8M vs $19.9M prior year; operating expenses down 20% to $18.2M.
- Reaffirmed full year 2026 revenue guidance of $16M-$18M (3% growth at midpoint).
- Ended Q1 with ~$220M cash and investments; repurchased ~1.5M shares in the quarter.
- Appointed Anthony (Tony) Bazarko as CCO; secured collaboration with Precision Health Research, Singapore (10,000 samples).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1726445/000119312526221696/0001193125-26-221696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1726445/000119312526221696/ck0001726445-20260513.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-221696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer